A detailed history of Pfm Health Sciences, LP transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pfm Health Sciences, LP holds 148,852 shares of VRTX stock, worth $67 Million. This represents 4.06% of its overall portfolio holdings.

Number of Shares
148,852
Previous 148,852 -0.0%
Holding current value
$67 Million
Previous $69.8 Million 0.78%
% of portfolio
4.06%
Previous 3.58%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $51.1 Million - $61.1 Million
148,852 New
148,852 $60.6 Million
Q2 2021

Aug 16, 2021

SELL
$187.49 - $221.1 $8.79 Million - $10.4 Million
-46,889 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$207.02 - $241.31 $9.71 Million - $11.3 Million
46,889 New
46,889 $10.1 Million
Q3 2020

Nov 16, 2020

SELL
$255.65 - $303.1 $15.1 Million - $17.9 Million
-59,035 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$225.48 - $295.8 $8.22 Million - $10.8 Million
-36,447 Reduced 38.17%
59,035 $17.1 Million
Q1 2020

May 15, 2020

BUY
$199.77 - $247.81 $7.7 Million - $9.56 Million
38,560 Added 67.74%
95,482 $22.7 Million
Q4 2019

Feb 14, 2020

BUY
$166.71 - $223.91 $9.49 Million - $12.7 Million
56,922 New
56,922 $12.5 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Pfm Health Sciences, LP Portfolio

Follow Pfm Health Sciences, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.